An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Clinical trial NCT02257736 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02257736
- Sponsor
- Aragon Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-26
- Primary completion
- 2018-03-19
- Enrollment
- 982
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.